Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?

Aras, BD; Isik, S; Teke, HU; Aslan, A; Yavasoglu, F; Gulbas, Z; Demirkan, F; Ozen, H; Cilingir, O; Inci, NS; Gunden, G; Bulduk, T; Gokalp, EE; Kocagil, S; Artan, S; Akay, OM

Aras, BD (corresponding author), Univ Eskisehir Osmangazi, Fac Med, Dept Med Genet, Prof Dr Nabi Avci St 4, TR-26040 Eskisehir, Buyukdere, Turkey.

MOLECULAR CYTOGENETICS, 2021; 14 (1):

Abstract

Background: Deletion of 13q14 [del(13q)] is the most common cytogenetic change (50%) in chronic lymphoblastic leukemia (CLL), and it is a good prognos......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索